Pharmaceutical quality assurance (QA) is a comprehensive and systematic approach designed to ensure that medicinal products consistently meet predetermined standards of quality, safety, identity, strength, purity and efficacy throughout their intended lifecycle. The contemporary pharmaceutical industry has moved beyond a predominantly end-product testing model toward integrated, science-based and risk-based quality management. Good Manufacturing Practices (GMP), Pharmaceutical Quality Systems (PQS), Quality Risk Management (QRM), Quality by Design (QbD), validation, qualification, change control, deviation management, corrective and preventive action (CAPA), supplier qualification, documentation and data integrity constitute major components of modern pharmaceutical QA. International regulatory frameworks developed by the World Health Organization (WHO), International Council for Harmonisation (ICH), United States Food and Drug Administration (FDA) and other regulatory bodies increasingly emphasize lifecycle management, continual improvement and reliable data. The 2024 tenth edition of the WHO pharmaceutical quality assurance compendium provides an updated global framework extending from pharmaceutical development and manufacturing to quality control and post-marketing surveillance. Recent advances in digitalization, artificial intelligence (AI), machine learning (ML), Process Analytical Technology (PAT), continuous manufacturing and advanced data analytics are further transforming pharmaceutical quality management. However, these technologies also introduce challenges related to validation, data integrity, cyber security, model governance and regulatory acceptance. This review discusses the fundamental concepts, major components, regulatory framework, implementation strategies, current challenges and emerging trends in pharmaceutical quality assurance. An integrated lifecycle-based QA system supported by scientific understanding, risk management, robust documentation, quality culture and appropriate technology is essential for ensuring consistent product quality and protecting patient safety.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: